ATYR 241018 2.50C (ATYR241018C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

ATYR241018C2500

Watchlist

0.10
0.000.00%

15min DelayClose Oct 4 16:00 ET

0.10High0.05Low

Intraday

5D
Daily

News

ATyr Pharma Initiated at Overweight by Wells Fargo
Dow JonesOct 4 10:10 ET · Ratings
ATyr Pharma Price Target Announced at $17.00/Share by Wells Fargo
Dow JonesOct 4 10:10 ET · Ratings
ATyr Pharma ATYR Phase 1b/2a Data; Summit SMMT Enrollment Completed
BioPharmCatalystOct 4 08:11 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
BenzingaOct 4 08:07 ET
ATyr Pharma Announces Publication Demonstrating Efficacy Of Efzofitimod In Pulmonary Sarcoidosis In The European Respiratory Journal
BenzingaOct 2 08:15 ET
Jefferies Initiates ATyr Pharma(ATYR.US) With Buy Rating, Announces Target Price $9
Moomoo NewsSep 5 08:31 ET · Ratings

Comments

Jaguar8

Oct 2 20:03

NEWS

$aTyr Pharma (ATYR.US)$
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
Post hoc analysis of Phase 1b/2a study demonstrated statistically significant difference in time-to-first-relapse for corticosteroid use in therapeutic (3.0 and 5.0 mg/kg efzofitimod) vs subtherapeutic (1.0 mg/kg efzofitimod and placebo) groups.
54.4% of patients in the subtherapeutic group relapsed following corticosteroid taper, compar...

test dummy

Jul 22 20:11

$aTyr Pharma (ATYR.US)$ prolly gonna get shorted heavily today